Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 1, p. s520, 2025. DOI: 10.25251/skin.9.supp.520. Disponível em: https://skin.dermsquared.com/skin/article/view/3163. Acesso em: 26 oct. 2025.